| EPB251 | Virological failure and acquired drug resistance among ART-experienced people living with HIV in Nepal: a nationally representative surveillance study | E-poster | Resistance to ART |
| EPE053 | Virological outcomes and ARV switch profiles one year after dolutegravir transition among children in southern Mozambique | E-poster | Implementation science of scaling up HIV treatment |
| EPE397 | Virtual HIV counseling: How to access MSM and transgender people in rural areas in Paraguay in the context of the COVID-19 pandemic | E-poster | Impact of COVID-19 on HIV testing services |
| EPA032 | Virtual memory CD8+ T-cells exhibit highly cytotoxic profiles in people with HIV, and are expanded by N-803 | E-poster | Cellular immunity; T cell vaccines |
| EPD532 | Virtual monitoring, evaluation and learning on HIV service accessibility during COVID 19: learnings & best practices | E-poster | Social and behavioural aspects and approaches to COVID-19 |
| EPD001 | Visual access to create greater comprehension: Incorporating the visual arts into a representational analysis of HIV community dialogue on living with HIV and a quality of life | E-poster | Community engagement in research and research dissemination |
| EPA085 | Vitamin D supplementation enhances cytotoxic response in patients with severe COVID-19 | E-poster | Immune responses to SARS-Cov2 |
| EPE393 | Voluntary Medical Male Circumcision (VMMC) service model rebranding amidst novel corona virus-19 (COVID-19) pandemic in meeting set targets in Zambia | E-poster | Impact of COVID-19 on HIV prevention services |
| EPB047 | Voriconazole or amphotericin B deoxycholate: which is the preferred induction therapy in HIV-infected patients with talaromycosis? | E-poster | Opportunistic infections (excluding TB): Bacterial, non-TB mycobacterial, viral and parasitic infections |
| EPF161 | Water and food insecurity are linked with increased HIV vulnerabilities during the COVID-19 pandemic among urban refugee youth in Kampala, Uganda | E-poster | Impact of COVID-19 on HIV risk and HIV care among refugees, migrants, asylum seekers and internally displaced persons |